Jacek Mackiewicz

2.3k total citations
37 papers, 745 citations indexed

About

Jacek Mackiewicz is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jacek Mackiewicz has authored 37 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Jacek Mackiewicz's work include Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (13 papers) and CAR-T cell therapy research (8 papers). Jacek Mackiewicz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (13 papers) and CAR-T cell therapy research (8 papers). Jacek Mackiewicz collaborates with scholars based in Poland, Italy and France. Jacek Mackiewicz's co-authors include Andrzej Maćkiewicz, Tomasz Kolenda, Katarzyna Lamperska, Anna Teresiak, Kacper Guglas, Anna Kozłowska, Renata Bliźniak, Jean‐Jacques Grob, Vanna Chiarion‐Sileni and Joelle Lufkin and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Jacek Mackiewicz

34 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacek Mackiewicz Poland 15 397 292 212 178 107 37 745
Guang Wu China 20 540 1.4× 239 0.8× 273 1.3× 192 1.1× 90 0.8× 48 927
Tao Pan China 11 315 0.8× 227 0.8× 157 0.7× 94 0.5× 122 1.1× 22 627
Adele M. Nicolas Germany 7 333 0.8× 293 1.0× 195 0.9× 251 1.4× 177 1.7× 8 767
Samuel A. Kerk United States 15 611 1.5× 240 0.8× 282 1.3× 98 0.6× 176 1.6× 21 967
Massimo Moro Italy 19 578 1.5× 386 1.3× 396 1.9× 125 0.7× 118 1.1× 39 1.0k
Qianqian Lei China 16 514 1.3× 213 0.7× 333 1.6× 145 0.8× 82 0.8× 39 831
Dan Zang China 18 486 1.2× 237 0.8× 166 0.8× 68 0.4× 115 1.1× 39 804
Yang Cheng China 13 343 0.9× 142 0.5× 194 0.9× 144 0.8× 93 0.9× 25 621
Xue Chen China 12 377 0.9× 284 1.0× 199 0.9× 76 0.4× 259 2.4× 26 750
Chaoxin Hu United States 13 434 1.1× 367 1.3× 128 0.6× 97 0.5× 47 0.4× 18 920

Countries citing papers authored by Jacek Mackiewicz

Since Specialization
Citations

This map shows the geographic impact of Jacek Mackiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Mackiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Mackiewicz more than expected).

Fields of papers citing papers by Jacek Mackiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Mackiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Mackiewicz. The network helps show where Jacek Mackiewicz may publish in the future.

Co-authorship network of co-authors of Jacek Mackiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Mackiewicz. A scholar is included among the top collaborators of Jacek Mackiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Mackiewicz. Jacek Mackiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tomela, Katarzyna, Łukasz Galus, Agnieszka Olejnik‐Schmidt, et al.. (2024). Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients. International Journal of Molecular Sciences. 25(23). 12982–12982. 1 indexed citations
3.
Tomela, Katarzyna, Łukasz Galus, Jacek Mackiewicz, et al.. (2023). Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells. 12(5). 789–789. 13 indexed citations
4.
Galus, Łukasz, Maurycy Jankowski, Michał Nowicki, et al.. (2023). Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients. Cells. 12(6). 856–856. 2 indexed citations
5.
Kazimierczak, Urszula, Tomasz Kolenda, Dariusz Kowalczyk, Jacek Mackiewicz, & Andrzej Maćkiewicz. (2020). BNIP3L Is a New Autophagy Related Prognostic Biomarker for Melanoma Patients Treated With AGI-101H. Anticancer Research. 40(7). 3723–3732. 4 indexed citations
6.
Czerwińska, Patrycja, Jacek Mackiewicz, Urszula Kazimierczak, et al.. (2018). Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients. OncoImmunology. 7(11). e1509821–e1509821. 16 indexed citations
7.
Kolenda, Tomasz, Kacper Guglas, Anna Teresiak, et al.. (2018). EGOT lncRNA in head and neck squamous cell carcinomas. Polish Journal of Pathology. 69(4). 356–365. 14 indexed citations
8.
Mackiewicz, Jacek & Andrzej Maćkiewicz. (2018). BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients. Współczesna Onkologia. 2018(1). 68–72. 48 indexed citations
9.
Mackiewicz, Jacek, Tomasz Burzykowski, Dariusz Iżycki, & Andrzej Maćkiewicz. (2018). Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results. Journal for ImmunoTherapy of Cancer. 6(1). 134–134. 12 indexed citations
10.
Guglas, Kacper, Tomasz Kolenda, Anna Teresiak, et al.. (2017). lncRNA in HNSCC: challenges and potential. Współczesna Onkologia. 21(4). 259–266. 68 indexed citations
11.
Mackiewicz, Jacek, et al.. (2016). Vismodegib — a chance for improvement of quality of life in patients with locally advanced basal cell carcinoma — a case report. Oncology in Clinical Practice. 12(1). 25–28. 1 indexed citations
12.
Mackiewicz, Jacek, et al.. (2015). Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma. Medicine. 94(21). e853–e853. 16 indexed citations
13.
14.
Krokowicz, Łukasz, et al.. (2014). Resistance to Vemurafenib Can Be Reversible After Treatment Interruption. Medicine. 93(27). e157–e157. 15 indexed citations
15.
Mackiewicz, Jacek, Piotr J. Wysocki, Anna Kozłowska, et al.. (2013). Immunotargeting melanoma stem cells with Hyper-IL6 modified whole cell therapeutic vaccine (AGI-101H) in patients with advanced melanoma - a joint analysis of two phase 2 studies. Document Server@UHasselt (UHasselt).
16.
Kozłowska, Anna, Jacek Mackiewicz, & Andrzej Maćkiewicz. (2013). Therapeutic gene modified cell based cancer vaccines. Gene. 525(2). 200–207. 41 indexed citations
17.
Krokowicz, Łukasz, B Kaczmarek, Piotr Krokowicz, et al.. (2013). Sodium butyrate and short chain fatty acids in prevention of travellers' diarrhoea: A randomized prospective study. Travel Medicine and Infectious Disease. 12(2). 183–188. 27 indexed citations
18.
Mackiewicz, Jacek. (2012). What is new in the treatment of advanced melanoma? State of the art. Współczesna Onkologia. 5(5). 363–370. 8 indexed citations
19.
Mackiewicz, Jacek & Andrzej Maćkiewicz. (2012). Recent advances in melanoma treatment – American Society of Clinical Oncology (ASCO) 2012 perspective. Współczesna Onkologia. 3(3). 197–200. 3 indexed citations
20.
Mackiewicz, Jacek & Andrzej Maćkiewicz. (2009). Design of clinical trials for therapeutic cancer vaccines development. European Journal of Pharmacology. 625(1-3). 84–89. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang Wu Breakdown of academic impact, for papers by Tao Pan Breakdown of academic impact, for papers by Adele M. Nicolas Breakdown of academic impact, for papers by Samuel A. Kerk Breakdown of academic impact, for papers by Massimo Moro Breakdown of academic impact, for papers by Qianqian Lei Breakdown of academic impact, for papers by Dan Zang Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by Xue Chen Breakdown of academic impact, for papers by Chaoxin Hu
Rankless by CCL
2026